Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
No significant differences were observed between the groups in HbA1c, total cholesterol, HDL-C, triglycerides, creatinine, AST, phosphorus, magnesium, PTH, or serum 25(OH)D3 (all p > 0.05).
Source: 3.2. Differences in Biochemical Parameters According to Sarcopenia Status. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Secondary analysis.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Prevalence and Blood Biochemical Parameters Associated with Sarcopenia Among Korean Postmenopausal Women Aged 50 Years and Older: A Nationwide Cross-Sectional Study
Source: Article title.
The present study was a secondary analysis of publicly available KNHANES data.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Prevalence and Blood Biochemical Parameters Associated with Sarcopenia Among Korean Postmenopausal Women Aged 50 Years and Older: A Nationwide Cross-Sectional Study
Secondary analysis · Healthcare · 2026
Original publication title
Prevalence and Blood Biochemical Parameters Associated with Sarcopenia Among Korean Postmenopausal Women Aged 50 Years and Older: A Nationwide Cross-Sectional Study
© 2026 by the author.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: Highlights
What are the main findings?
- •
Using the AWGS 2025 age-specific criteria, the weighted prevalence of sarcopenia was 10.5% among Korean postmenopausal women aged ≥50 years and 9.7% among those aged 50 to 64 years.
- •
Higher triglycerides were associated with higher sarcopenia odds after adjustment for age, BMI, and age at menopause; higher hemoglobin was associated with lower odds after adjustment for age.
What are the implications of the main findings?
- •
The findings highlight the importance of attention to muscle health among postmenopausal women beginning in midlife.
- •
Blood biochemical parameters may have potential relevance to muscle health assessment among postmenopausal women, but their clinical utility requires further validation.
Abstract: Abstract
Background/Objectives:
Sarcopenia is a growing health concern from midlife, but evidence on its biochemical correlates among postmenopausal women younger than 65 years remains limited. This study aimed to estimate sarcopenia prevalence and explore associations with blood biochemical parameters among Korean postmenopausal women aged ≥50 years using the Asian Working Group for Sarcopenia (AWGS) 2025 age-specific diagnostic criteria.
Methods:
We analyzed 2024 Korea National Health and Nutrition Examination Survey data from 1157 postmenopausal women aged ≥50 years with complete muscle and biochemical measurements. The 13 biochemical parameters were glycated hemoglobin, total cholesterol, high-density lipoprotein cholesterol, triglycerides, hemoglobin, creatinine, aspartate aminotransferase, high-sensitivity C-reactive protein, calcium, phosphorus, magnesium, parathyroid hormone, and serum 25-hydroxyvitamin D3. Complex sample logistic regression examined each parameter’s association with sarcopenia, adjusting for age alone or age, body mass index (BMI), and age at menopause.
Results:
The weighted prevalence of sarcopenia was 10.5% overall and 9.7% among women aged 50 to 64 years. Triglycerides were not significantly associated with sarcopenia in the age-adjusted model. However, in the model adjusted for age, BMI, and age at menopause, each 10 mg/dL increase in triglyceride levels was associated with approximately 5.1% higher odds of sarcopenia (aOR = 1.051, 95% CI: 1.020 to 1.072, p < 0.001). Higher hemoglobin levels were associated with lower odds of sarcopenia in the age-adjusted model (aOR = 0.734, 95% CI: 0.599 to 0.901, p = 0.003). Both associations remained significant after false discovery rate correction.
Conclusions:
These findings highlight the importance of muscle health before older age in postmenopausal women. Biochemical parameters may have potential relevance to muscle health assessment, but their clinical utility requires further validation.
Authors’ abstract
Highlights
What are the main findings?
- •
Using the AWGS 2025 age-specific criteria, the weighted prevalence of sarcopenia was 10.5% among Korean postmenopausal women aged ≥50 years and 9.7% among those aged 50 to 64 years.
- •
Higher triglycerides were associated with higher sarcopenia odds after adjustment for age, BMI, and age at menopause; higher hemoglobin was associated with lower odds after adjustment for age.
What are the implications of the main findings?
- •
The findings highlight the importance of attention to muscle health among postmenopausal women beginning in midlife.
- •
Blood biochemical parameters may have potential relevance to muscle health assessment among postmenopausal women, but their clinical utility requires further validation.
Abstract
Background/Objectives:
Sarcopenia is a growing health concern from midlife, but evidence on its biochemical correlates among postmenopausal women younger than 65 years remains limited. This study aimed to estimate sarcopenia prevalence and explore associations with blood biochemical parameters among Korean postmenopausal women aged ≥50 years using the Asian Working Group for Sarcopenia (AWGS) 2025 age-specific diagnostic criteria.
Methods:
We analyzed 2024 Korea National Health and Nutrition Examination Survey data from 1157 postmenopausal women aged ≥50 years with complete muscle and biochemical measurements. The 13 biochemical parameters were glycated hemoglobin, total cholesterol, high-density lipoprotein cholesterol, triglycerides, hemoglobin, creatinine, aspartate aminotransferase, high-sensitivity C-reactive protein, calcium, phosphorus, magnesium, parathyroid hormone, and serum 25-hydroxyvitamin D3. Complex sample logistic regression examined each parameter’s association with sarcopenia, adjusting for age alone or age, body mass index (BMI), and age at menopause.
Results:
The weighted prevalence of sarcopenia was 10.5% overall and 9.7% among women aged 50 to 64 years. Triglycerides were not significantly associated with sarcopenia in the age-adjusted model. However, in the model adjusted for age, BMI, and age at menopause, each 10 mg/dL increase in triglyceride levels was associated with approximately 5.1% higher odds of sarcopenia (aOR = 1.051, 95% CI: 1.020 to 1.072, p < 0.001). Higher hemoglobin levels were associated with lower odds of sarcopenia in the age-adjusted model (aOR = 0.734, 95% CI: 0.599 to 0.901, p = 0.003). Both associations remained significant after false discovery rate correction.
Conclusions:
These findings highlight the importance of muscle health before older age in postmenopausal women. Biochemical parameters may have potential relevance to muscle health assessment, but their clinical utility requires further validation.
Publication and source details
Original title: Prevalence and Blood Biochemical Parameters Associated with Sarcopenia Among Korean Postmenopausal Women Aged 50 Years and Older: A Nationwide Cross-Sectional Study
Seongheui Kim
Healthcare · 2026
© 2026 by the author.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.This research received no external funding.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T21:28:23.837598+00:00
DOI: 10.3390/healthcare14203419 · PMC13704287